Virus production

Details Virus production Virus production

2007-09-18

2007-09-18

Campell, Bruce R. (Department: 1648)

Chemistry: molecular biology and microbiology

Virus or bacteriophage, except for viral vector or...

Recovery or purification

C435S070300, C435S091330, C435S349000, C435S388000, C435S407000

Reexamination Certificate

active

10871768

ABSTRACT:
An improved process for recovery of virus from allantoic fluid of virus-infected chick embryos. Virus associated with granular and fibrous debris in the allantoic fluid can be disassociated from the debris and recovered, thereby increasing viral yield. Dissociation can be achieved by subjecting the virus-debris complex to conditions of increased salt concentrations, e.g., 0.5 M or greater.

REFERENCES:
patent: 3105012 (1963-09-01), Brandon et al.
patent: 3316153 (1967-04-01), Van Frank
patent: 3470067 (1969-09-01), Neal et al.
patent: 3547779 (1970-12-01), Lampson et al.
patent: 3608071 (1971-09-01), Relyveld et al.
patent: 3627873 (1971-12-01), Moyer
patent: 3632745 (1972-01-01), Apostolov
patent: 3870598 (1975-03-01), Alexeeva et al.
patent: 3874999 (1975-04-01), Zaremba et al.
patent: 3919044 (1975-11-01), Melnick et al.
patent: 3962421 (1976-06-01), Neurath
patent: 4000257 (1976-12-01), Cano
patent: 4057626 (1977-11-01), Metzgar et al.
patent: 4138287 (1979-02-01), Andersson et al.
patent: 4206287 (1980-06-01), Hannoun et al.
patent: 4327182 (1982-04-01), Benedictus
patent: 4338296 (1982-07-01), Löbmann et al.
patent: 4356169 (1982-10-01), Simons et al.
patent: 4500512 (1985-02-01), Barme
patent: 4500513 (1985-02-01), Brown et al.
patent: 4724210 (1988-02-01), Oka et al.
patent: 4783411 (1988-11-01), Gabliks
patent: 4808518 (1989-02-01), Dorsett et al.
patent: 5506129 (1996-04-01), Sangar
patent: 5698433 (1997-12-01), Kistner et al.
patent: 5762939 (1998-06-01), Smith et al.
patent: 5824536 (1998-10-01), Webster et al.
patent: 5948410 (1999-09-01), Van Scharrenburg et al.
patent: 6008036 (1999-12-01), Fanget et al.
patent: 6048537 (2000-04-01), Violay et al.
patent: 6146873 (2000-11-01), Kistner et al.
patent: 6210683 (2001-04-01), Burke et al.
patent: 6267967 (2001-07-01), Johnston et al.
patent: 6344354 (2002-02-01), Webster et al.
patent: 6348197 (2002-02-01), Davelaar
patent: 6399357 (2002-06-01), Winge
patent: 6403363 (2002-06-01), Lawrence et al.
patent: 6455298 (2002-09-01), Gröner et al.
patent: 6579528 (2003-06-01), Dowling et al.
patent: 2003/0073223 (2003-04-01), Groner et al.
patent: 2003/0087417 (2003-05-01), Peeters et al.
patent: 2003/0108918 (2003-06-01), Castor et al.
patent: 2003/0165465 (2003-09-01), Roberts et al.
patent: 660109 (1951-10-01), None
patent: 1140316 (1969-01-01), None
patent: WO99/07834 (1999-02-01), None
patent: WO97/25415 (1997-07-01), None
patent: WO97/37001 (1997-10-01), None
patent: WO98/42373 (1998-10-01), None
patent: WO99/07834 (1999-02-01), None
patent: WO99/18799 (1999-04-01), None
patent: WO 99/28445 (1999-06-01), None
patent: WO99/28445 (1999-06-01), None
patent: WO 99/66045 (1999-12-01), None
patent: WO99/66045 (1999-12-01), None
patent: WO 00/15251 (2000-03-01), None
patent: WO 00/62735 (2000-10-01), None
patent: WO 02/12289 (2002-02-01), None
patent: WO 02/24876 (2002-03-01), None
patent: WO 02/28422 (2002-04-01), None
patent: WO 02/067983 (2002-09-01), None
patent: WO 02/087494 (2002-11-01), None
patent: WO 03/093463 (2003-11-01), None
Goyal et al.; Sinple Methods for the Concentration of Influenza Virus from Allantoic Fluid on Microporous Filters; Applied ans Enviromental Microbiology, Mar. 1980, p. 500-504.
DJS Arora et al.; Concentration and Purification of INfluenza Virus from Allantoic Fluid, Jul. 23, 1984; Analytical Biochemistry 144, 189-192 (1985).
Wallis et al. Concentration and Purification of Influenza Virus on Insoluble Polyelectolytes, Applied Microbiology, Apr. 1972, vol. 23, No. 4, pp. 740-744.
Reimer et al., Purification of Large Quantities of Influenza Virus by Density Gradient Centrifugation, Journal of Virology, Dec. 1967, vol. 1, No. 6, pp. 1207-1216.
Breschkin et al. “Hemagglutination Variant of Measles Virus,”Virology, 80:441-444 (1997).
Chaloupka et al., “Comparative Analysis of Six European Influenza Vaccines,”Eur. J. Clin. Microbiol. Infect. Dis., 15:121-127 (1996).
Dea et al., “Bovine Coronavirus and Cultivation in Continuous Cell Lines,”Am. J. Vet. Res. 41(1):30-38 (Jan. 1980).
Eggert et al., “Characterization of RNA Polymerase Activity of Highly Purified Preparations of the Influenza Virus A/duck/Alberta/48/76,”Zbl. Bakt. Hyg. A256:534-.
Floyd et al., “Viral Aggregation: Effects of Salts on the Aggregation of Poliovirus and Reovirus at Low pH,”Appl. Envir. Microbiol., 35:1084-1094 (Jun. 1978).
Gaudin et al., “Aggregation of VSV M Protein Is Reversible and Mediated by Nucleation Sites: Implications for Viral Assembly,”Virology, 206:28-37 (1995).
Götze et al., “Immunogenicity And Partial Purification Of Soluble H-2 Antigens Extracted With Hypertonic Salt,”J. Immunol., 112(5):1643-1651 (May, 1974).
Han et al., “pH-dependent Self-association of Influenza Hemagglutinin Fusion Peptides in Lipid Bilayers,”J. Mol. Biol., 304:953-965 (2000).
Ikizler et al., “Thermostabilization of egg grown influenza viruses,”Vaccine, 20:1393-1399 (2002).
James et al., “Safe administration of influenza vaccine to patients with egg allergy,”J. Pediatrics, 133(5):624-628 (Nov. 1998).
Johnston et al., “Reversible Inhibition of Sindbis Virus Penetration in Hypertonic Medium,”J. Virol., 25(1):436-438 (Jan. 1978).
Karakuyumchan et al., “Freeing Rabies Virus Of The Neuroallergenic Factor From Brain Tissue,”Acta virol., 25:155-158 (1981).
Lance et al., “Effect of Ionic Composition of Suspending Solution on Virus Adsoption by a Soil Column,”Appl. Envir. Microbiol., 47:484-488 (Mar. 1984).
Lukasik et al., “Influence of Salts on Virus Adsorption to Microporous Filters,”Appl. Envir. Microbiol., 66(7):2914-2920 (Jul. 2000).
Mabrouk et al., “Influenza vaccine technologies and the use of the cell-culture process (cell-culture influenza vaccine),”Dev Biol. 110:125-134 (2002) Abstract.
Makhov et al., “The phenomenon of the conversion of filamentous virions of the influenza virus into spherical particles,” (Translation), (Voprosy Virusologii, 34(2):274-279 (1989).
Molodkina et al., “Flow ultramicroscopy investigation of the aggregate stability of influenza virus dispersions,”Colloids and Surfaces A:Physicochemical and Engineering Aspects, 98:1-9 (1995).
Nagy et al., “Purificaton Of Influenza Virus Vaccine Stock Suspension By Ion-Exchange Chromatography,”Acta Microbiologica Academiae Scienitiarum Hungariae, 25:134-135 (1978).
Oxford et al., “Direct isolation in eggs of influenza A (H1N1) and B viruses with haemagglutinins of different antigenic and amino acid compositions,”J. Gen. Virol., 72:185-189 (1991).
Pauli et al., “Increase of virus yields and releases of Borna disease virus from persistently infected cells,”Virus Research, 2:29-33 (1985).
Robertson et al., “The role of amniotic passage in the egg-adaptation of human influenza virus is revealed by haemagglutinin sequence analyses,”J. Gen. Virol., 74:2047-2051 (1993).
Sampson et al., “Relationship between food-specific IgE concentrations and the risk of positive food challenges in children and adolescents,”J. Allergy Clin. Immunol., 100(4) (Oct. 1997)—website: www.2.us.elsevierhealth.com/scripts/om.dll/serve.
Sampson, “Food allergy, Part 2: Diagnosis and management,”J. Allergy Clin. Immunol., 103(6):981-989 (Jun. 1999).
Sampson, “Utility of food-specific IgE concentrations in predicting symptomatic food allergy,”J. Allergy Clin. Immunol., 107(8):891-896 (May 2001).
Shields et al., “Influence of Salts on Electrostatic Interactions Between Poliovirus and Membrane Filters,”Appl. Environ. Microbiol., 45:526-531 (Feb. 1983).
Stevely et al., “The Effect Of Hypertonic Conditions On Protein Synthesis In Cells Infected With Herpes Virus,”FEBS Lett., 87(2):308-310 (Mar. 1978).
Stigter et al., “Charge Effects on Folded and Unfolded Proteins,”Biochemistry, 29:1262-1271 (1990).
Eggert et al., “Char

Affiliated with

Also associated with

Rating

Virus production does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Virus production, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Virus production will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3788241